EUVIMEDEUVIMED entdecken
Crossref

Seizure control in women with epilepsy undergoing assisted reproductive technology

Aisha A Abdulrazaq iD, Alessandra J Ainsworth, Jeffrey W Britton, Chandra C Shenoy, Samir N Babayev, Gregory D Cascino, Kelsey M Smith iD

Epilepsia · 2023

DOI: 10.1111/epi.17748 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Epilepsia, 2023. Verfasst von Aisha A Abdulrazaq und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA. Hauptthemen laut MEDLINE: Reproductive Techniques, Assisted, Epilepsy, Seizures. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 16 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The objective of this study was to determine seizure control in women with epilepsy (WWE) undergoing assisted reproductive technology (ART). Through retrospective chart review, WWE undergoing ART were identified. Demographics and details regarding epilepsy type, seizure control, and ART procedures were extracted. Seizure frequency prior to and during ART were compared. We identified 12 WWE, who underwent 29 embryo transfers, resulting in 16 pregnancies and 10 live births. Nine women were seizure‐free at least 2 years before fertility treatment, including three with resolved epilepsy. Seven were on antiseizure medications throughout fertility treatment and pregnancy, with only one on polytherapy. Eleven (all with controlled epilepsy or epilepsy in remission) remained seizure‐free throughout fertility treatment. One woman with drug‐resistant epilepsy continued to have seizures throughout fertility treatment and pregnancy without an exacerbation of seizure frequency. There was no increased seizure frequency associated with fertility treatment and subsequent pregnancy in this small series of WWE. Although this study was statistically underpowered, our results provide some preliminary evidence that ART might not pose a threat to seizure control, but larger, confirmatory studies are necessary.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Reproductive Techniques, AssistedEpilepsySeizuresHumansFemaleAdultPregnancyRetrospective StudiesAnticonvulsantsPregnancy ComplicationsEmbryo TransferYoung Adult

Stichwörter der Autor:innen

antiseizure medicationsassisted reproductive technologyin vitro fertilizationwomen with epilepsy

Substanzen

Anticonvulsants

Autor:innen und Institutionen

  • Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA.
  • Department of Obstetrics and Gynecology, Mayo Clinic, Rochester, Minnesota, USA.

ORCID-Profile: Aisha A Abdulrazaq, Kelsey M Smith

Zitieren

APA

Abdulrazaq, A. A., Ainsworth, A. J., Britton, J. W., Shenoy, C. C., Babayev, S. N., Cascino, G. D., & Smith, K. M. (2023). Seizure control in women with epilepsy undergoing assisted reproductive technology. Epilepsia. https://doi.org/10.1111/epi.17748

Vancouver

Abdulrazaq AA, Ainsworth AJ, Britton JW, Shenoy CC, Babayev SN, Cascino GD, et al. Seizure control in women with epilepsy undergoing assisted reproductive technology. Epilepsia. 2023. doi:10.1111/epi.17748

BibTeX
@article{Abdulrazaq2023,
  author = {Abdulrazaq, Aisha A and Ainsworth, Alessandra J and Britton, Jeffrey W and Shenoy, Chandra C and Babayev, Samir N and Cascino, Gregory D and Smith, Kelsey M},
  title = {Seizure control in women with epilepsy undergoing assisted reproductive technology},
  journal = {Epilepsia},
  year = {2023},
  doi = {10.1111/epi.17748}
}
Kostenlos starten →